Michele Carbone
Michele Carbone
Email verificata su cc.hawaii.edu
TitoloCitata daAnno
Germline BAP1 mutations predispose to malignant mesothelioma
JR Testa, M Cheung, J Pei, JE Below, Y Tan, E Sementino, NJ Cox, ...
Nature genetics 43 (10), 1022, 2011
6212011
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients
RM Flores, HI Pass, VE Seshan, J Dycoco, M Zakowski, M Carbone, ...
The Journal of thoracic and cardiovascular surgery 135 (3), 620-626. e3, 2008
5192008
Simian virus 40-like DNA sequences in human pleural mesothelioma.
M Carbone, HI Pass, P Rizzo, M Marinetti, MM Di, DJ Mew, AS Levine, ...
Oncogene 9 (6), 1781-1790, 1994
4981994
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
Y Ohta, V Shridhar, RK Bright, GP Kalemkerian, W Du, M Carbone, ...
British journal of cancer 81 (1), 54, 1999
4341999
The pathogenesis of mesothelioma
M Carbone, RA Kratzke, JR Testa
Seminars in oncology 29 (1), 2-17, 2002
4262002
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
HI Pass, D Lott, F Lonardo, M Harbut, Z Liu, N Tang, M Carbone, C Webb, ...
New England Journal of Medicine 353 (15), 1564-1573, 2005
3922005
Benign and malignant mesothelioma.
KH Antman
Cancer: principles and practice of oncology, 1853-1878, 1997
302*1997
Simian virus-40 large-T antigen binds p53 in human mesotheliomas
M Carbone, P Rizzo, PM Grimley, A Procopio, DJY Mew, V Shridhar, ...
Nature medicine 3 (8), 908, 1997
2951997
Cancer and inflammation: promise for biological therapy
S Demaria, E Pikarsky, M Karin, LM Coussens, YC Chen, EM El-Omar, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (4), 335, 2010
2922010
BAP1 and cancer
M Carbone, H Yang, HI Pass, T Krausz, JR Testa, G Gaudino
Nature Reviews Cancer 13 (3), 153, 2013
2852013
SV40 induces mesotheliomas in hamsters.
C Cicala, F Pompetti, M Carbone
The American journal of pathology 142 (5), 1524, 1993
2741993
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
I Roushdy-Hammady, J Siegel, S Emri, JR Testa, M Carbone
The Lancet 357 (9254), 444-445, 2001
2582001
Malignant mesothelioma: facts, myths, and hypotheses
M Carbone, BH Ly, RF Dodson, I Pagano, PT Morris, UA Dogan, ...
Journal of cellular physiology 227 (1), 44-58, 2012
2552012
Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity
M Bocchetta, I Di Resta, A Powers, R Fresco, A Tosolini, JR Testa, ...
Proceedings of the National Academy of Sciences 97 (18), 10214-10219, 2000
2532000
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
H Yang, M Bocchetta, B Kroczynska, AG Elmishad, Y Chen, Z Liu, ...
Proceedings of the National Academy of Sciences 103 (27), 10397-10402, 2006
2522006
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
A De Luca, A Baldi, V Esposito, CM Howard, L Bagella, P Rizzo, M Caputi, ...
Nature medicine 3 (8), 913, 1997
2301997
SV40 and human tumours: myth, association or causality?
AF Gazdar, JS Butel, M Carbone
Nature Reviews Cancer 2 (12), 957, 2002
2252002
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma
HI Pass, SM Levin, MR Harbut, J Melamed, L Chiriboga, J Donington, ...
New England Journal of Medicine 367 (15), 1417-1427, 2012
2222012
SV40-like sequences in human bone tumors.
M Carbone, P Rizzo, A Procopio, M Giuliano, HI Pass, MC Gebhardt, ...
Oncogene 13 (3), 527-535, 1996
2201996
Simian virus 40, poliovaccines and human tumors: a review of recent developments
M Carbone, P Rizzo, HI Pass
Oncogene 15 (16), 1877, 1997
2091997
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20